Parse Wipes Out 10x Genomics Patents Ahead of March Trial

Parse Biosciences Inc. convinced an administrative tribunal to invalidate two 10x Genomics Inc. cell-analysis patents its products are accused of infringing.

10x’s US Patent Nos. 10,240,197 and 10,697,013 are obvious in light of two prior patent applications and a scientific journal article, according to decisions issued Jan. 31 and Monday by the Patent Trial and Appeal Board.

• 10x sued Parse in August 2022 in the US District Court for the District of Delaware, alleging Parse’s Evercode WT products and its single-cell test infringe three of its patents and three patents it licenses from Stanford University.
• Parse petitioned the PTAB to ...